Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil

被引：17

作者：

Dias de Matos, Marcia Alves ^{[1
]}

Ferreira, Renata Carneiro ^{[1
]}

Rodrigues, Fabiana Perez ^{[2
]}

Marinho, Tamiris Augusto ^{[1
]}

Rodrigues Lopes, Carmen Luci ^{[2
]}

Magalhaes Novais, Antonia Carlos ^{[4
]}

Coimbra Motta-Castro, Ana Rita ^{[3
]}

Teles, Sheila Araujo ^{[2
]}

Dutra Souto, Francisco Jose ^{[4
]}

Bringel Martins, Regina Maria ^{[1
]}

机构：

[1] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil

[2] Univ Fed Goias, Fac Enfermagem, Goiania, Go, Brazil

[3] Univ Fed Mato Grosso do Sul, Dept Farm Bioquim, Campo Grande, MS, Brazil

[4] Univ Fed Mato Grosso, Fac Ciencias Med, Cuiaba, MT, Brazil

来源：

MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2013年 / 108卷 / 03期

关键词：

hepatitis B virus; occult infection; genotypes; GENETIC DIVERSITY; VIRAL-HEPATITIS; HIGH PREVALENCE; RISK-FACTORS; GENOTYPES; EPIDEMIOLOGY;

D O I：

10.1590/S0074-02762013000300019

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

The prevalence of occult hepatitis B virus (HBV) infection was investigated in 149 hepatitis B surface antigen (HBsAg) negative injecting drug users (IDUs) in the Central-West Region of Brazil. Of these individuals, 19 were positive for HBV DNA, resulting in an occult HBV infection prevalence of 12.7% (19/149); six of these 19 individuals had anti-HBV core and/or anti-HBV surface antibodies and 13 were negative for HBV markers. All IDUs with occult hepatitis B reported sexual and/or parenteral risk behaviours. All HBV DNA-positive samples were successfully genotyped. Genotype D was the most common (17/19), followed by genotype A (2/19). These findings reveal a high prevalence of occult HBV infection and the predominance of genotype D among IDUs in Brazil's Central-West Region.

引用

页码：386 / 389

页数：4

共 50 条

[41] Acceptability of hepatitis C virus testing methods among injecting drug users
White, Bethany
Day, Carolyn
Thein, Hla Hla
Doab, Anna
Bates, Anna
Holden, Joanne
van Beek, Ingrid
Maher, Lisa
DRUG AND ALCOHOL REVIEW, 2008, 27 (06) : 666 - 670
[42] Hepatitis C infection among injecting drug users in Scotland: Stemming the flow
Goldberg, D
Taylor, A
Hutchinson, S
McMenamin, J
SCOTTISH MEDICAL JOURNAL, 2000, 45 (05) : 131 - 132
[43] Prevention of hepatitis C infection among injecting drug users in Northeast India
Medhi, G. K.
Mahanta, J.
CURRENT SCIENCE, 2008, 94 (05): : 557 - 558
[44] A computer model of the spread of hepatitis C virus among injecting drug users
Mather, D
Crofts, N
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (01) : 5 - 10
[45] Distribution of Hepatitis C virus genotypes among injecting drug users in Lebanon
Ramia, S.
Mahfoud, Z.
Kreidieh, K.
Shamra, S.
Kassak, K.
JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S31 - S31
[46] A computer model of the spread of hepatitis C virus among injecting drug users
Dineli Mather
Nick Crofts
European Journal of Epidemiology, 1999, 15 : 5 - 10
[47] Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon
Mahfoud, Ziyad
Kassak, Kassem
Kreidieh, Khalil
Shamra, Sarah
Ramia, Sami
VIROLOGY JOURNAL, 2010, 7
[48] Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon
Ziyad Mahfoud
Kassem Kassak
Khalil Kreidieh
Sarah Shamra
Sami Ramia
Virology Journal, 7
[49] Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
Akhtar, Abdul Majeed
Majeed, Sadia
Jamil, Muhammad
Rehman, Abdul
Majeed, Sufia
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (02) : 373 - 378
[50] Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study
van Beek, I
Dwyer, R
Dore, GJ
Luo, KH
Kaldor, JM
BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7156): : 433 - 437

← 1 2 3 4 5 →